Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 100 of 399 entries
View as:
Phase: N/A
Priority: Normal
Start: 01/31/18
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 10/10/14
End: 08/20/20
Due: 08/20/21
Phase: N/A
Priority: Normal
Start: 09/30/98
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 04/11/23
End: 06/06/24
Due: 06/06/25
Phase: N/A
Priority: Normal
Start: 04/30/07
End: 05/31/14
Due: 05/31/15
Phase: N/A
Priority: Normal
Start: 09/30/06
End: 09/30/09
Due: 09/30/10
Phase: N/A
Priority: Normal
Start: 08/19/24
End: 09/01/26
Due: 09/01/27
Phase: N/A
Priority: Normal
Start: 12/14/12
End: 06/08/17
Due: 06/08/18
Phase: N/A
Priority: Normal
Start: 06/08/10
End: 10/01/18
Due: 10/01/19
Phase: N/A
Priority: Normal
Start: 03/31/02
End: 07/31/04
Due: 07/31/05
Phase: N/A
Priority: Normal
Start: 08/31/98
End: 01/31/01
Due: 01/31/02
Buparlisib, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Advanced Solid Tumors
Phase: N/A
Priority: Normal
Start: 09/30/15
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/30/12
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 12/17/19
End: 11/10/22
Due: 11/10/23
Phase: N/A
Priority: Normal
Start: 01/31/99
End: 01/31/04
Due: 01/31/05
Phase: N/A
Priority: Normal
Start: 03/31/98
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 04/24/15
End: 06/14/18
Due: 06/14/19
Phase: N/A
Priority: Normal
Start: 12/31/08
End: 08/31/13
Due: 08/31/14
Phase: N/A
Priority: Normal
Start: 12/31/13
End: 08/31/14
Due: 08/31/15
Phase: N/A
Priority: Normal
Start: 10/31/02
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 08/31/00
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 10/19/18
End: 03/09/21
Due: 03/09/22
Phase: N/A
Priority: Normal
Start: 09/05/12
End: 05/29/14
Due: 05/29/15
Phase: N/A
Priority: Normal
Start: 12/31/04
End: 04/30/13
Due: 04/30/14
Phase: N/A
Priority: Normal
Start: 05/31/97
End: 05/31/04
Due: 05/31/05